Skip to main content

Published locations for Erythropoietin for HCV May Lack Clinical Benefit : The drug's expense along with its unproven survival benefit are enough to signal caution in many settings.

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Erythropoietin for HCV May Lack Clinical Benefit : The drug's expense along with its unproven survival benefit are enough to signal caution in many settings.

User login

  • Reset your password
  • /content/erythropoietin-hcv-may-lack-clinical-benefit-drugs-expense-along-its-unproven-survival
  • /internalmedicinenews/article/15356/gastroenterology/erythropoietin-hcv-may-lack-clinical-benefit
  • /internalmedicine/article/15356/gastroenterology/erythropoietin-hcv-may-lack-clinical-benefit-drugs